DSE:PURABIGEN Statistics

Total Valuation

DSE:PURABIGEN has a market cap or net worth of BDT 1.17 billion. The enterprise value is 368.92 million.

Market Cap	1.17B
Enterprise Value	368.92M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	Jun 26, 2024

Share Statistics

DSE:PURABIGEN has 59.81 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	59.81M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 11.30.

PE Ratio	11.30
Forward PE	n/a
PS Ratio	4.52
PB Ratio	1.41
P/TBV Ratio	1.41
P/FCF Ratio	14.63
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.33, with an EV/FCF ratio of 4.61.

EV / Earnings	3.56
EV / Sales	1.42
EV / EBITDA	2.33
EV / EBIT	2.38
EV / FCF	4.61

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.01.

Current Ratio	2.22
Quick Ratio	1.28
Debt / Equity	0.01
Debt / EBITDA	0.05
Debt / FCF	0.11
Interest Coverage	238.91

Financial Efficiency

Return on equity (ROE) is 12.73% and return on invested capital (ROIC) is 11.81%.

Return on Equity (ROE)	12.73%
Return on Assets (ROA)	6.49%
Return on Invested Capital (ROIC)	11.81%
Return on Capital Employed (ROCE)	16.80%
Revenue Per Employee	4.18M
Profits Per Employee	1.67M
Employee Count	62
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.21% in the last 52 weeks. The beta is 0.69, so DSE:PURABIGEN's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-31.21%
50-Day Moving Average	19.63
200-Day Moving Average	22.15
Relative Strength Index (RSI)	51.52
Average Volume (20 Days)	30,440

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:PURABIGEN had revenue of BDT 259.12 million and earned 103.76 million in profits. Earnings per share was 1.73.

Revenue	259.12M
Gross Profit	203.95M
Operating Income	154.82M
Pretax Income	154.45M
Net Income	103.76M
EBITDA	157.45M
EBIT	154.82M
Earnings Per Share (EPS)	1.73

Full Income Statement

Balance Sheet

The company has 811.94 million in cash and 8.53 million in debt, giving a net cash position of 803.40 million or 13.43 per share.

Cash & Cash Equivalents	811.94M
Total Debt	8.53M
Net Cash	803.40M
Net Cash Per Share	13.43
Equity (Book Value)	832.26M
Book Value Per Share	13.91
Working Capital	776.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 85.92 million and capital expenditures -5.82 million, giving a free cash flow of 80.11 million.

Operating Cash Flow	85.92M
Capital Expenditures	-5.82M
Free Cash Flow	80.11M
FCF Per Share	1.34

Full Cash Flow Statement

Margins

Gross margin is 78.71%, with operating and profit margins of 59.75% and 40.04%.

Gross Margin	78.71%
Operating Margin	59.75%
Pretax Margin	59.60%
Profit Margin	40.04%
EBITDA Margin	60.76%
EBIT Margin	59.75%
FCF Margin	30.91%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 5.10%.

Dividend Per Share	1.00
Dividend Yield	5.10%
Dividend Growth (YoY)	47.14%
Years of Dividend Growth	1
Payout Ratio	45.78%
Buyback Yield	n/a
Shareholder Yield	5.10%
Earnings Yield	8.85%
FCF Yield	6.83%

Dividend Details

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 1.03.

Last Split Date	Aug 7, 2023
Split Type	Forward
Split Ratio	1.03

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a